5' UTR contains an ORF described as a putative conserved uORF (FBrf0204849); potential peptide 41aa in length.
Low-frequency RNA-Seq exon junction(s) not annotated.
Gene model reviewed during 5.46
Gene model reviewed during 5.56
Click to get a list of regulatory features (enhancers, TFBS, etc.) and gene disruptions (point mutations, indels, etc.) within or overlapping Dmel\fend using the Feature Mapper tool.
Maternally-expressed fend transcript is localized to the yolk. Zygotic fend transcript is expressed in presumptive neurogenic regions. Starting at embryonic stage 14, fend is dynamically expressed in subsets of cells in the central nervous system; these include a segmentally repeated medial cluster at the ventral plane of the ventral nerve cord, and a lateral cluster at a more dorsal plane. fend transcript is also expressed in the peripheral nervous system, including lateral chordotonal organ lch5 at late embryonic stages. At stage 13-15, fend transcipt is expressed in the lateral epidermis immediately posterior to the segmental border. fend transcript is also expressed in heart precursor cells from embryonic stages 13-17.
GBrowse - Visual display of RNA-Seq signalsView Dmel\fend in GBrowse 2
Please Note This section lists cDNAs and ESTs that fall within the genomic extent of the gene model, which may include cDNAs and ESTs of genes within introns, or of overlapping genes. Please see GBrowse for alignment of the cDNAs and ESTs to the gene model.
For each fully sequenced cDNA the DGRC maintains various forms of the cDNA (e.g tagged or untagged) in several different host vectors for subsequent cloning and expression in Drosophila and Drosophila cell lines.
Source for merge of: ld14 BcDNA:RH56795